RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
PARP inhibitors, RanBP9, Cisplatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要